All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 11 points (-0.1%) at 17,856 as of Thursday, Nov. 5, 2015, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,091 issues advancing vs. 1,846 declining with 161 unchanged.

The Health Services industry currently sits down 0.9% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Intersect ENT ( XENT), down 24.2%, Kindred Healthcare ( KND), down 18.2%, HCA Holdings ( HCA), down 0.9% and CVS Health ( CVS), down 0.6%. Top gainers within the industry include Amedisys ( AMED), up 8.6%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.6%, Aetna ( AET), up 1.0%, Humana ( HUM), up 0.9% and Becton Dickinson ( BDX), up 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Universal Health Services ( UHS) is one of the companies pushing the Health Services industry lower today. As of noon trading, Universal Health Services is down $1.76 (-1.4%) to $123.26 on light volume. Thus far, 304,729 shares of Universal Health Services exchanged hands as compared to its average daily volume of 901,500 shares. The stock has ranged in price between $121.34-$125.14 after having opened the day at $124.99 as compared to the previous trading day's close of $125.03.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $11.3 billion and is part of the health care sector. Shares are up 12.4% year-to-date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Universal Health Services a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Universal Health Services Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, CR Bard ( BCR) is down $1.77 (-0.9%) to $185.48 on light volume. Thus far, 110,787 shares of CR Bard exchanged hands as compared to its average daily volume of 619,500 shares. The stock has ranged in price between $184.99-$188.93 after having opened the day at $186.91 as compared to the previous trading day's close of $187.25.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. CR Bard has a market cap of $13.9 billion and is part of the health care sector. Shares are up 12.4% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts that rate CR Bard a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates CR Bard as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and disappointing return on equity. Get the full CR Bard Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, Intuitive Surgical ( ISRG) is down $4.05 (-0.8%) to $497.40 on light volume. Thus far, 81,131 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 327,100 shares. The stock has ranged in price between $496.00-$504.33 after having opened the day at $501.85 as compared to the previous trading day's close of $501.45.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States, Europe, and Asia. Intuitive Surgical has a market cap of $18.8 billion and is part of the health care sector. Shares are down 5.2% year-to-date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Intuitive Surgical Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).